SummaryWe report the solid-phase synthesis and receptor-binding properties of eleven oxytocin analogs (Mpa-XxxIle-Gln-Asn-Cys-Sar-Arg-Gly-NH2) containing non-coded amino acids in position 2: D-a-and L-ot-(2-indanyl)glycine, R,S-6-methoxy-2-aminotetralin-2-carboxylic acid, D-and L-pentafluorophenylalanine, D,L-2,4-dimethylphenylalanine, D,L-2,4,6-trimethylphenylalanine, R,R-and S,S-1,2,3,4-tetrahydro-1-methyl-fl-carboline-3-carboxylic acid and R-and S-1,2,3,4-tetrahydro-fl-carboline-3-carboxylic acid. Some of these amino acid analogs (2-indanylglycine and D-pentafluorophenylalanine) were earlier successfully applied for the synthesis of potent bradykinin antagonists [1,2]. Their receptor bindings were tested on isolated guinea-pig uterus, rat liver and rat kidney inner medulla plasma membranes. The extent of binding of the peptides to the Oxytocin receptor was in several cases was even higher than that of the parent hormone (oxytocin). However, the real pharmacological value of these analogs can be evaluated only after in vivo measurements of their inhibition of uterine motor activity.Abbreviations: Symbols and abbreviations are in accordance with the recommendations of the IUPAC-IUB Joint Commission on Biochemical Nomenclature: Nomenclature and Symbolism for Amino Acids and Peptides [3]. The following other abbreviations were used: AcN,